Revascularization in the rabbit hindlimb: dissociation between capillary sprouting and arteriogenesis

被引:145
作者
Hershey, JC
Baskin, EP
Glass, JD
Hartman, HA
Gilberto, DB
Rogers, IT
Cook, JJ
机构
[1] Merck & Co Inc, Merck Res Labs, Dept Pharmacol, W Point, PA 19486 USA
[2] Merck & Co Inc, Merck Res Labs, Lab Anim Resources, W Point, PA 19486 USA
关键词
angiogenesis; arteries; blood flow; collateral circulation; growth factors; ischemia;
D O I
10.1016/S0008-6363(00)00232-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Animal models of hindlimb ischemia are critical to our understanding of peripheral vascular disease and allow us to evaluate therapeutic strategies aimed to improve peripheral collateral circulation. To further elucidate the processes involved in revascularization following ischemia, we evaluated the temporal association between tissue ischemia, vascular endothelial cell growth factor (VEGF) release, angiogenesis (capillary sprouting), arteriogenesis (growth of the larger muscular arteries), and reserve blood flow (functional collateral flow). Methods: New Zealand White rabbits (male 3-4 kg) were evaluated at specific days (0, 5, 10, 20 or 40) following femoral artery removal for measurement of hindlimb blood Row, skeletal muscle lactate production and VEGF content, capillary density (a marker of angiogenesis), and angiographic score (a marker of arteriogenesis). Results: Maximal capillary sprouting occurred within 5 days of femoral artery removal and was temporally associated with reduced resting hindlimb blood flow, increased lactate release and detectable levels of skeletal muscle VEGF. The growth of larger angiographically visible collateral vessels occurred after 10 days and was not temporally associated with ischemia or skeletal muscle VEGF content, but did coincide with a large functional improvement in the reserve blood flow capacity of the limb. Conclusions: Following femoral artery removal in the rabbit, the time course of angiogenesis and arteriogenesis were clearly distinct. Tissue ischemia and/or VEGF may stimulate capillary sprouting, but this response does not translate to a significant improvement in collateral flow. The growth and development of the larger collateral vessels was correlated with a large functional improvement in collateral Row, and occurred at a time when VEGF levels were undetectable. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:618 / 625
页数:8
相关论文
共 37 条
  • [1] Monocyte activation in angiogenesis and collateral growth in the rabbit hindlimb
    Arras, M
    Ito, WD
    Scholz, D
    Winkler, B
    Schaper, J
    Schaper, W
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (01) : 40 - 50
  • [2] ENHANCED ANGIOGENESIS AND GROWTH OF COLLATERALS BY INVIVO ADMINISTRATION OF RECOMBINANT BASIC FIBROBLAST GROWTH-FACTOR IN A RABBIT MODEL OF ACUTE LOWER-LIMB ISCHEMIA - DOSE-RESPONSE EFFECT OF BASIC FIBROBLAST GROWTH-FACTOR
    BAFFOUR, R
    BERMAN, J
    GARB, JL
    RHEE, SW
    KAUFMAN, J
    FRIEDMANN, P
    [J]. JOURNAL OF VASCULAR SURGERY, 1992, 16 (02) : 181 - 191
  • [3] Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal
    Benjamin, LE
    Golijanin, D
    Itin, A
    Pode, D
    Keshet, E
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (02) : 159 - 165
  • [4] Buschmann I, 2000, J PATHOL, V190, P338, DOI 10.1002/(SICI)1096-9896(200002)190:3<338::AID-PATH594>3.0.CO
  • [5] 2-7
  • [6] Cheng TT, 1998, J CHIN INST CHEM ENG, V29, P327
  • [7] Vascular endothelial growth factor - A jack-of-all-trades or a nonspecific stress gene?
    Clauss, M
    Schaper, W
    [J]. CIRCULATION RESEARCH, 2000, 86 (03) : 251 - 252
  • [8] ROLE OF THE FLT-1 RECEPTOR TYROSINE KINASE IN REGULATING THE ASSEMBLY OF VASCULAR ENDOTHELIUM
    FONG, GH
    ROSSANT, J
    GERTSENSTEIN, M
    BREITMAN, ML
    [J]. NATURE, 1995, 376 (6535) : 66 - 70
  • [9] Angiogenic gene therapy - A leg to stand on?
    Fox, JC
    Swain, JL
    [J]. CIRCULATION, 1996, 94 (12) : 3065 - 3066
  • [10] FROMMER JP, 1983, MED CLIN N AM, V67, P815